McKesson to source drugs for Albertsons store pharmacies; CPhI annual report suggests FDA change plant approvals;

> Drug distributor McKesson ($MCK) says that it will now take on sourcing and distribution of both generic and branded drugs from the 1,700 pharmacies at Albertsons stores. Release

> In a new CPhI annual report ahead of its show in Madrid, pharma consultant Girish Malhotra suggests that, if certain conditions are met, the FDA allow drugmakers to begin commercializing improvements to their processes without waiting for a reinspection. Release

> Biocon has opened its new manufacturing facility to make injection pens and other devices for its insulin products. Report

> Glassware maker Wheaton says it has been acquired by the Duran Group. Release (PDF)

> Indian pharma consultant Piramal Pharma Solutions says it will be spreading the word at the annual CPhI meeting in Madrid that drugmakers need to look for ways to "embrace green chemistry" by dedicating themselves to continuous improvements. Release

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.